Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2013-03-01
Серии:Frontiers in Oncology
Предметы:
p53
tumor suppressor
Glioblastoma Multiforme
WWOX
temozolomide resistance
Online-ссылка:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы